FBXO21介导的p85α降解调控急性髓系白血病的增殖与生存
该研究探讨F-box泛素E3连接酶FBXO21在急性髓系白血病(AML)中的作用。在AML细胞系和原代患者样本中沉默FBXO21可导致分化、抑制肿瘤进展并增敏化疗,同时上调细胞因子信号通路。蛋白质组学分析发现FBXO21泛素化p85α促进其降解,从而降低PI3K信号、增加游离p85α二聚化并激活ERK。
要点
- FBXO21在AML中低表达,但表达水平与患者生存相关,高表达者预后更差。
- 沉默FBXO21可诱导AML细胞分化、抑制肿瘤进展并增敏化疗。
- FBXO21通过泛素化p85α促进其降解,进而下调PI3K信号并激活ERK。
核心结论
- FBXO21作为泛素E3连接酶,通过调控p85α蛋白稳定性改变PI3K信号,在AML发病机制中起关键作用。
研究设计与样本
- 研究在人源AML细胞系和原代患者样本中进行,采用基因沉默和基于质谱的蛋白质组学分析。
主要发现
- 在AML细胞系和原代患者样本中沉默FBXO21导致分化、抑制肿瘤进展并增敏化疗药物。
- 敲低FBXO21导致细胞因子信号通路上调。
- FBXO21泛素化p85α(PI3K通路的调节亚基)并促其降解,导致PI3K信号降低、游离p85α二聚化和ERK激活。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by clonal expansion of myeloid blasts in the bone marrow (BM). Despite advances in therapy, the prognosis for AML patients remains poor, and there is a need to identify novel molecular pathways regulating tumor cell survival and proliferation. F-box ubiquitin E3 ligase, FBXO21, has low expression in AML, but expression correlates with survival in AML patients and patients with higher expression have poorer outcomes. Silencing FBXO21 in human-derived AML cell lines and primary patient samples leads to differentiation, inhibition of tumor progression, and sensitization to chemotherapy agents. Additionally, knockdown of FBXO21 leads to up-regulation of cytokine signaling pathways. Through a mass spectrometry-based proteomic analysis of FBXO21 in AML, we identified that FBXO21 ubiquitylates p85α, a regulatory subunit of the phosphoinositide 3-kinase (PI3K) pathway, for degradation resulting in decreased PI3K signaling, dimerization of free p85α and ERK activation. These findings reveal the ubiquitin E3 ligase, FBXO21, plays a critical role in regulating AML pathogenesis, specifically through alterations in PI3K via regulation of p85α protein stability.
引用
- Dobish KK, Wittorf KJ, Swenson SA, et al. FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia. Leukemia. 2023. PMID: 37689825. doi:10.1038/s41375-023-02020-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。